BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Semakula JR, Mouton JP, Jorgensen A, Hutchinson C, Allie S, Semakula L, French N, Lamorde M, Toh CH, Blockman M, Sekaggya-Wiltshire C, Waitt C, Pirmohamed M, Cohen K. A cross-sectional evaluation of five warfarin anticoagulation services in Uganda and South Africa. PLoS One 2020;15:e0227458. [PMID: 31995565 DOI: 10.1371/journal.pone.0227458] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Semakula JR, Kisa G, Mouton JP, Cohen K, Blockman M, Pirmohamed M, Sekaggya-Wiltshire C, Waitt C. Anticoagulation in sub-Saharan Africa: Are direct oral anticoagulants the answer? A review of lessons learnt from warfarin. Br J Clin Pharmacol 2021. [PMID: 33624331 DOI: 10.1111/bcp.14796] [Reference Citation Analysis]
2 Mouton JP, Blockman M, Sekaggya-Wiltshire C, Semakula J, Waitt C, Pirmohamed M, Cohen K. Improving anticoagulation in sub-Saharan Africa: What are the challenges and how can we overcome them? Br J Clin Pharmacol 2021;87:3056-68. [PMID: 33586223 DOI: 10.1111/bcp.14768] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Asiimwe IG, Waitt C, Sekaggya-Wiltshire C, Hutchinson C, Okello E, Zhang EJ, Semakula JR, Mouton JP, Cohen K, Blockman M, Lamorde M, Jorgensen AL, Pirmohamed M. Developing and Validating a Clinical Warfarin Dose-Initiation Model for Black-African Patients in South Africa and Uganda. Clin Pharmacol Ther 2021;109:1564-74. [PMID: 33280090 DOI: 10.1002/cpt.2128] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Sridharan K, Banny RA, Husain A. Evaluation of Stable Doses of Warfarin in a Patient Cohort. Drug Res (Stuttg) 2020;70:570-5. [PMID: 32820470 DOI: 10.1055/a-1228-5033] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Mwita JC, Damasceno A, Chillo P, Ogah OS, Cohen K, Oyekunle A, Tefera E, Francis JM; AAREN Investigators. Vitamin K-dependent anticoagulant use and level of anticoagulation control in sub-Saharan Africa: protocol for a retrospective cohort study. BMJ Open 2022;12:e057166. [PMID: 35105600 DOI: 10.1136/bmjopen-2021-057166] [Reference Citation Analysis]
6 Noviyani R, Youngkong S, Nathisuwan S, Bagepally BS, Chaikledkaew U, Chaiyakunapruk N, McKay G, Sritara P, Attia J, Thakkinstian A. Economic evaluation of direct oral anticoagulants (DOACs) versus vitamin K antagonists (VKAs) for stroke prevention in patients with atrial fibrillation: a systematic review and meta-analysis. BMJ Evid Based Med 2021:bmjebm-2020-111634. [PMID: 34635480 DOI: 10.1136/bmjebm-2020-111634] [Reference Citation Analysis]
7 Yabeyu AB, Ayanaw MA, Haile KT, Kifle ZD. Evaluation of patients' knowledge of warfarin at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia. Metabol Open 2022;13:100155. [PMID: 34917918 DOI: 10.1016/j.metop.2021.100155] [Reference Citation Analysis]
8 Jacobs MS, Adeoye AM, Owolabi MO, Tieleman RG, Postma MJ, Van Hulst M. Screening for Atrial Fibrillation in Sub-Saharan Africa: A Health Economic Evaluation to Assess the Feasibility in Nigeria. Glob Heart 2021;16:80. [PMID: 34900571 DOI: 10.5334/gh.893] [Reference Citation Analysis]